Previous Close | 47.66 |
Open | 47.07 |
Bid | 47.76 x 1200 |
Ask | 48.24 x 3100 |
Day's Range | 47.05 - 48.27 |
52 Week Range | 34.98 - 48.87 |
Volume | |
Avg. Volume | 6,571,531 |
Market Cap | 68.88B |
Beta (5Y Monthly) | 0.82 |
PE Ratio (TTM) | 62.54 |
EPS (TTM) | 0.77 |
Earnings Date | Jan 31, 2023 - Feb 06, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 48.95 |
In this article we are going to estimate the intrinsic value of Boston Scientific Corporation ( NYSE:BSX ) by...
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope system with the ability to monitor intrarenal pressure in real-time during ureteroscopy procedures.
Boston Scientific ( NYSE:BSX ) Full Year 2022 Results Key Financial Results Revenue: US$12.7b (up 6.7% from FY 2021...